Respiratory Syncytial Virus

In this video, William Schaffner, MD, provides an overview of the topics presented at the 2023 Annual Conference on Vaccinology Research, hosted by the National Foundation for Infectious Diseases, including...

The FDA approved the use of Pfizer’s bivalent prefusion f vaccine in older adults to protect against respiratory syncytial virus. A Pfizer spokesperson answered questions about the study that helped lead to...

Are there benefits to vaccinating women who are pregnant with a vaccine that prevents respiratory syncytial virus (RSV)-related illness in newborns? A new study examined this topic.

In this video, Ashley Tippett, MPH, MLS(ASCP)cm, Khalel De Castro, and Christina A. Rostad, MD, speak about the social risk factors associated with older adults diagnosed with respiratory syncytial virus...

In this multidisciplinary roundtable discussion, Albert Rizzo, MD, interviews Barbara Taylor, MD, MS, and Leonard R. Krilov, MD, about recommendations and indications for vaccines against RSV, including in...

In this video, Ashish Bhargava, MD, discusses the results of his team's study on the risk factors associated with a longer hospital stay in adult patients with respiratory syncytial virus (RSV. He talks...

In this multidisciplinary roundtable discussion, Albert Rizzo, MD, interviews Barbara Taylor, MD, MS, and Leonard R. Krilov, MD, about guidelines in the management of patients with RSV, including pediatrics...

In this video roundtable episode, Jaspal Singh, MD, MHA, MHS, interviews Lisa Davidson, MD, Katie Passaretti, MD, and Amina Ahmed, MD, about the recently approved vaccines to protect against Respiratory...

In this podcast, John Harrington, MD, speaks about the “triple threat” of viral respiratory infections in children during the winter of 2022-2023, including COVID-19, influenza, and respiratory syncytial...